RSS

Issue 19.7

With emerging biotechs playing a critical part in developing new drugs, Merck attempts to understand the interactions between parties when manufacturing monoclonal antibodies (mAbs). Read more

, , , Opinion

Alan Baines, director, Testing Solutions at Lonza BioScience explains how automated systems are improving every aspect of endotoxin testing workflows. Read more

Opinion

Felix Faupel, head of contract manufacturing at Acino talks to EPM about the biggest challenges of being a contract manufacturer. Read more

Opinion

Kyle Hogan, director of eClinical Solutions at Clinical Ink explains how clinical research is benefitting from data collection technologies. Read more

News

EPM speaks to a number of key players in contract manufacturing to get their thoughts on the sector’s changing landscape. Read more

Opinion

How GSK has embraced a new Augmented Reality (AR) app from BakerHicks to validate the design of a new Aseptic Manufacturing Facility at Barnard Castle. Read more

Technology

Aiden Flynn, founder of analytical solutions company Exploristics answers some of the most pressing questions relating to clinical trials. Read more

Opinion

What benefits does an embedded CDMO model bring and how Pfizer CentreOne operates within one of the world’s premier biopharmaceutical companies. Read more

Opinion

Barley Laing, UK managing director at Melissa explains why a new type of artificial intelligence could help solve problems for pharma researchers. Read more

Opinion

Alba Tiley, head of sustainability at Centrient Pharmaceuticals discusses why a sustainable to developing antibiotics is key to combatting antimicrobial resistance (AMR). Read more

Opinion

Reece Armstrong writes about Brexit's impact on pharma one last time and looks ahead to CPhI Worldwide. Read more

News

With the emergence of CBD-based medicines, Sarath Chandar, chief scientific officer, SPI Pharma guides readers through the bioavailability challenges facing this sector of the industry. Read more

Opinion